MiÑao, Ligaya D.

HRN: 00-33-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2022
AZITHROMYCIN 500MG TABLET (TAB)
07/19/2022
07/25/2022
ORAL
500 Mg
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Duration 

Overall appropriateness: No  Wrong Duration

Intervention



Type of Intervention done:

                    

           


Acceptance: